Biotron Ltd
BIT•Health Care•Biotechnology•Last updated: Dec 25
About
Biotron Ltd is an Australian biotechnology company focused on the development of antiviral therapies. The company specializes in the design and development of small molecule drugs that target viral proteins, with a primary focus on treating HIV-1 and Hepatitis C. Biotron's lead product, BIT225, is in clinical development for the treatment of HIV-1 and Hepatitis C infections.
Share Price Chart
Company Details
- Sector
- Health Care
- Industry
- Biotechnology
- ASX Code
- BIT
Related Shares
Investor Resources
Should you buy Biotron Ltd right now?
While BIT looks interesting right now, our experts have just put together a full report on the ultimate ASX investment portfolio - designed for growth and passive income.
Join the Rask weekly investment newsletter to get the names, right now